Literature DB >> 15864624

Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane.

Norbert Kociok1, Claudia Gavranic, Bernd Kirchhof, Antonia M Joussen.   

Abstract

PURPOSE: This study was conducted to investigate whether macrophage activation through cell membrane attachment might be supported by emulsified tamponade droplets of a certain vesicle size. It has been hypothesized that emulsification of vitreous tamponades might stimulate retinal membrane formation.
METHODS: In this laboratory investigation, similarly sized vesicles of silicone oil and the partially fluorinated alkane perfluorohexyloctane (F6H8) were produced by extrusion through polycarbonate membranes. Human neutrophils were obtained from blood donors. Human monocytes were negatively isolated from mononuclear cells by depletion of other cells. Cell activation status of phagocyting blood neutrophils was measured by a chemiluminescence assay. Fluorescent attached or internalized vesicles were monitored by fluorescent microscopy. The main outcome measures were the altered activation status of monocytes after vesicle incubation and the ability of human macrophages to attach and/or internalize vesicles in vitro.
RESULTS: Extruding silicone oil through a polycarbonate membrane resulted in the production of vesicles that remained stable for at least 2 days. F6H8 vesicles had to be stabilized with an emulsifier, in this case Pluronic PE6800 or Lipoid EPC. The mean vesicle diameter was similar with both components (F6H8: 13.08+/-2.95 microm, silicone oil: 10.05+/-4.6 microm). Neutrophil activation was not influenced by either emulsifier alone or by silicone oil vesicles without emulsifier. Stabilized F6H8 vesicles had a dose-dependent influence on blood neutrophil activation. Only silicone oil vesicles together with Lipoid EPC, not Pluronic PE6800, had a comparable influence on neutrophil activation. Neutrophil activation was influenced neither by 0.125% human serum albumin (HSA) alone nor by vesicles of F6H8 or silicone oil prepared with 0.125% HSA. Monocyte cell membrane attachment of silicone fluid was two times higher than that of F6H8 fluid. F6H8/Pluronic PE6800 vesicles enhanced this process 20-fold, whereas silicone oil vesicles did not enhance cell membrane attachment significantly.
CONCLUSIONS: These in vitro data do not support the hypothesis that emulsification of the tamponades silicone oil or F6H8 in the microenvironment of the eye might easily activate neutrophils or stimulate phagocytosis by monocytes. A prerequisite is the combination of a vesicle shape of the tamponades with specific stabilizing or modifying surfactants. Emulsified tamponades stabilized by artificial surfactants, but not by the naturally occurring protein HSA, favor cell activation by cell membrane attachment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15864624     DOI: 10.1007/s00417-004-1039-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  28 in total

1.  Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.

Authors:  R C Allen; L D Loose
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

2.  Small-volume extrusion apparatus for preparation of large, unilamellar vesicles.

Authors:  R C MacDonald; R I MacDonald; B P Menco; K Takeshita; N K Subbarao; L R Hu
Journal:  Biochim Biophys Acta       Date:  1991-01-30

3.  Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution.

Authors:  D Zeana; J Becker; R Kuckelkorn; B Kirchhof
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

4.  Semifluorinated alkanes--a new class of compounds with outstanding properties for use in ophthalmology.

Authors:  H Meinert; T Roy
Journal:  Eur J Ophthalmol       Date:  2000 Jul-Sep       Impact factor: 2.597

5.  Experimental vitreous replacement with perfluorotributylamine.

Authors:  S Chang; N J Zimmerman; T Iwamoto; R Ortiz; D Faris
Journal:  Am J Ophthalmol       Date:  1987-01-15       Impact factor: 5.258

6.  Low viscosity liquid fluorochemicals in vitreous surgery.

Authors:  S Chang
Journal:  Am J Ophthalmol       Date:  1987-01-15       Impact factor: 5.258

7.  Retinal tolerance to intravitreal perfluoroethylcyclohexane liquid in the rabbit.

Authors:  J R Sparrow; G P Matthews; T Iwamoto; R Ross; A Gershbein; S Chang
Journal:  Retina       Date:  1993       Impact factor: 4.256

8.  Perfluorinated organic liquid as an intraocular oxygen reservoir for the ischemic retina.

Authors:  C A Wilson; B A Berkowitz; R Srebro
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-01       Impact factor: 4.799

9.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.

Authors:  D C Litzinger; A M Buiting; N van Rooijen; L Huang
Journal:  Biochim Biophys Acta       Date:  1994-02-23

10.  Fluorescent carbocyanine dyes allow living neurons of identified origin to be studied in long-term cultures.

Authors:  M G Honig; R I Hume
Journal:  J Cell Biol       Date:  1986-07       Impact factor: 10.539

View more
  11 in total

1.  Surgical results of heavy silicone oil HWS-45 3000 as internal tamponade for inferior retinal detachment with PVR: a pilot study.

Authors:  Stanislao Rizzo; Maria Chiara Romagnoli; Federica Genovesi-Ebert; Claudia Belting
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-15       Impact factor: 3.117

2.  Inhibition of migration but stimulation of proliferation of human retinal pigment epithelial cells cultured with uniform vesicles of silicone oil.

Authors:  Li-Na Ma; Yan-Nian Hui; Yu-Sheng Wang; Le Zhang; Ji-Xian Ma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-27       Impact factor: 3.117

Review 3.  The concept of heavy tamponades-chances and limitations.

Authors:  Antonia M Joussen; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

4.  Effect of gravity in long-term vitreous tamponade: in vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes.

Authors:  Jerzy Mackiewicz; Kristel Maaijwee; Christoph Lüke; Norbert Kociok; Wilfried Hiebl; Hasso Meinert; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-11       Impact factor: 3.535

5.  COHORT SAFETY AND EFFICACY STUDY OF SILURON2000 EMULSIFICATION-RESISTANT SILICONE OIL AND F4H5 IN THE TREATMENT OF FULL-THICKNESS MACULAR HOLE.

Authors:  Peter Stalmans; Anne-Marie Pinxten; David S Wong
Journal:  Retina       Date:  2015-12       Impact factor: 4.256

Review 6.  Heavy silicone oil and intraocular inflammation.

Authors:  Francesco Morescalchi; Ciro Costagliola; Sarah Duse; Elena Gambicorti; Barbara Parolini; Barbara Arcidiacono; Mario R Romano; Francesco Semeraro
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

7.  What Is the Cause of Toxicity of Silicone Oil?

Authors:  Ying Chen; Yan Lam Ip; Liangyu Zhou; Pik Yi Li; Yee Mei Chan; Wai Ching Lam; Kenneth Kai Wang Li; David H Steel; Yau Kei Chan
Journal:  Materials (Basel)       Date:  2021-12-30       Impact factor: 3.623

8.  Long-Term Safety and Efficacy of Siluron2000 with Pars Plana Vitrectomy in the Treatment of Patients with Severe Vitreoretinopathy and Chronic Macular Holes.

Authors:  Parnian Arjmand; Tina Felfeli; Efrem D Mandelcorn; Mark S Mandelcorn
Journal:  Clin Ophthalmol       Date:  2021-11-02

9.  Comparative Study of Chemical Composition, Molecular and Rheological Properties of Silicone Oil Medical Devices.

Authors:  Raniero Mendichi; Alberto Giacometti Schieroni; Daniele Piovani; Davide Allegrini; Mariantonia Ferrara; Mario R Romano
Journal:  Transl Vis Sci Technol       Date:  2019-09-11       Impact factor: 3.283

Review 10.  Silicone oil: different physical proprieties and clinical applications.

Authors:  Francesco Barca; Tomaso Caporossi; Stanislao Rizzo
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.